EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metapath-guided topology and domain knowledge fusion for predicting miRNA–drug–disease triplet resistance and sensitivity associations

Nan Sheng iD, Ling Gao, Xiongfeng Tang, Yunzhi Liu, Lan Huang, Yan Wang iD

Briefings in Bioinformatics · 02.11.2026 · 27 (6)

DOI: 10.1093/bib/bbag579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 07.11.2026. Verfasst von Nan Sheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key laboratory of Symbol Computation and Knowledge Engineering of Ministry of Education, College of Computer Science and Technology, Jilin University…. Hauptthemen laut MEDLINE: MicroRNAs, Drug Resistance, Neoplasm, Computational Biology, Breast Neoplasms. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, Jilin Provincial Scientific and Technological Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurately predicting drug resistance and sensitivity is critical for understanding disease treatment mechanisms and improving therapeutic strategies. MicroRNAs (miRNAs) play essential roles in regulating drug response. However, existing computational methods mainly focus on miRNA–drug pairwise associations and overlook the disease-specific context. In this study, we propose a metapath-guided topology and domain knowledge fusion framework (MTDKF) for predicting miRNA–drug–disease triplet resistance (MRDR) and sensitivity (MRDS) associations. Specifically, we construct a triplet heterogeneous graph to model the interactions among miRNAs, drugs, and diseases. A metapath topology view encoder is designed to capture regulatory patterns between nodes. Additionally, a domain knowledge view encoder is introduced to incorporate sequence, structural, and semantic features of biological entities. These two views are further integrated to learn robust and discriminative representation. We manually curate two benchmark datasets from experimentally validated associations. Extensive experimental results demonstrate that MTDKF consistently outperforms state-of-the-art approaches across multiple evaluation metrics. Furthermore, case studies on two breast cancer drugs doxorubicin and tamoxifen demonstrate its potential in discovering novel miRNAs related to drug resistance and sensitivity under disease-specific contexts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsDrug Resistance, NeoplasmComputational BiologyBreast NeoplasmsHumansDoxorubicinAlgorithmsTamoxifenFemale

Stichwörter der Autor:innen

domain knowledgedrug resistance and sensitivityheterogeneous graphmetapathmiRNA–drug–disease association

Substanzen

MicroRNAsDoxorubicinTamoxifen

Autor:innen und Institutionen

  • Key laboratory of Symbol Computation and Knowledge Engineering of Ministry of Education, College of Computer Science and Technology, Jilin University, No. 2699 Qianjin Street, Changchun 130012, China.
  • The Orthopaedic Medical Center, Second Hospital of Jilin University, No. 218 Ziqiang Street, Changchun 130022, China.

ORCID-Profile: Nan Sheng, Yan Wang

Förderung

  • China Postdoctoral Science Foundation
  • Jilin Provincial Scientific and Technological Development Program

Zitieren

APA

Sheng, N., Gao, L., Tang, X., Liu, Y., Huang, L., & Wang, Y. (2026). Metapath-guided topology and domain knowledge fusion for predicting miRNA–drug–disease triplet resistance and sensitivity associations. Briefings in Bioinformatics, 27(6). https://doi.org/10.1093/bib/bbag579

Vancouver

Sheng N, Gao L, Tang X, Liu Y, Huang L, Wang Y. Metapath-guided topology and domain knowledge fusion for predicting miRNA–drug–disease triplet resistance and sensitivity associations. Briefings in Bioinformatics. 2026;27(6). doi:10.1093/bib/bbag579

BibTeX
@article{Sheng2026,
  author = {Sheng, Nan and Gao, Ling and Tang, Xiongfeng and Liu, Yunzhi and Huang, Lan and Wang, Yan},
  title = {Metapath-guided topology and domain knowledge fusion for predicting miRNA–drug–disease triplet resistance and sensitivity associations},
  journal = {Briefings in Bioinformatics},
  year = {2026},
  volume = {27},
  number = {6},
  doi = {10.1093/bib/bbag579}
}
Kostenlos starten →